|  Join

Education

Congenital Toxoplasmosis Prevention

SMFM member, Dr. Laurent Mandelbrodt, discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii.  The results were presented at the SMFM Annual Pregnancy Meeting in February 2018. 

Key:

Complete
Failed
Available
Locked
Congenital Toxoplasmosis Prevention
Recorded 04/10/2018
Recorded 04/10/2018 SMFM member, Dr. Laurent Mandelbrodt, discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
Satisfaction Survey
2 Questions
2 Questions Please provide feedback on your experience.